TITLE
Chronic phase chronic myelogenous leukemia: CD34+ hematopoietic stem and progenitor cells

SUMMARY
Analysis of CD34+ hematopoietic stem and progenitor cells from the bone marrow of untreated patients with chronic myelogenous leukemia (CML) in first chronic phase. Results provide insight into the pathogenesis of chronic phase CML.

ORGANISM
Homo sapiens

PLATFORM
GPL201 : [HG-Focus] Affymetrix Human HG-Focus Target Array

CITATIONS
Diaz-Blanco E, Bruns I, Neumann F, Fischer JC et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 2007 Mar;21(3):494-504. PMID:  17252012 Abraham SA, Hopcroft LE, Carrick E, Drotar ME et al. Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells. Nature 2016 Jun 16;534(7607):341-6. PMID:  27281222

